Search Results - "CARLSEN, Janette"
-
1
[18F]Galacto-RGD Positron Emission Tomography for Imaging of αvβ3 Expression on the Neovasculature in Patients with Squamous Cell Carcinoma of the Head and Neck
Published in Clinical cancer research (15-11-2007)“…Purpose: [ 18 F]Galacto-RGD has been developed for positron emission tomography (PET)–imaging of αvβ3 expression, a receptor involved in angiogenesis and…”
Get full text
Journal Article -
2
Sequence-defined cMET/HGFR-targeted Polymers as Gene Delivery Vehicles for the Theranostic Sodium Iodide Symporter (NIS) Gene
Published in Molecular therapy (01-08-2016)“…The sodium iodide symporter (NIS) as well-characterized theranostic gene represents an outstanding tool to target different cancer types allowing noninvasive…”
Get full text
Journal Article -
3
Cross-sectional comparison of small animal [18F]-florbetaben amyloid-PET between transgenic AD mouse models
Published in PloS one (23-02-2015)“…We aimed to compare [18F]-florbetaben PET imaging in four transgenic mouse strains modelling Alzheimer's disease (AD), with the main focus on APPswe/PS2 mice…”
Get full text
Journal Article -
4
Correlation of perfusion MRI and 18F-FDG PET imaging biomarkers for monitoring regorafenib therapy in experimental colon carcinomas with immunohistochemical validation
Published in PloS one (10-02-2015)“…To investigate a multimodal, multiparametric perfusion MRI / 18F-fluoro-deoxyglucose-(18F-FDG)-PET imaging protocol for monitoring regorafenib therapy effects…”
Get full text
Journal Article -
5
Imaging Characteristics of DHOG, a Hepatobiliary Contrast Agent for Preclinical MicroCT in Mice
Published in Academic radiology (01-03-2008)“…Rationale and Objectives This study was performed to assess the imaging characteristics and pharmacokinetics of…”
Get full text
Journal Article -
6
Mesenchymal stem cell-mediated, tumor stroma-targeted radioiodine therapy of metastatic colon cancer using the sodium iodide symporter as theranostic gene
Published in Journal of Nuclear Medicine (01-04-2015)“…The tumor-homing property of mesenchymal stem cells (MSCs) allows targeted delivery of therapeutic genes into the tumor microenvironment. The application of…”
Get full text
Journal Article -
7
Thyroid hormones and tetrac: new regulators of tumour stroma formation via integrin αvβ3
Published in Endocrine-related cancer (01-12-2015)“…To improve our understanding of non-genomic, integrin αvβ3-mediated thyroid hormone action in tumour stroma formation, we examined the effects of…”
Get full text
Journal Article -
8
Imaging of integrin αvβ3 expression in patients with malignant glioma by [18F] Galacto-RGD positron emission tomography
Published in Neuro-oncology (Charlottesville, Va.) (01-12-2009)“…Inhibitors targeting the integrin α v β 3 are promising new agents currently tested in clinical trials for supplemental therapy of glioblastoma multiforme…”
Get full text
Journal Article -
9
Automated Spatial Brain Normalization and Hindbrain White Matter Reference Tissue Give Improved [(18)F]-Florbetaben PET Quantitation in Alzheimer's Model Mice
Published in Frontiers in neuroscience (29-02-2016)“…Preclinical PET studies of β-amyloid (Aβ) accumulation are of growing importance, but comparisons between research sites require standardized and optimized…”
Get full text
Journal Article -
10
Imaging of integrin alpha(v)beta(3) expression in patients with malignant glioma by [18F] Galacto-RGD positron emission tomography
Published in Neuro-oncology (Charlottesville, Va.) (01-12-2009)“…Inhibitors targeting the integrin alpha(v)beta(3) are promising new agents currently tested in clinical trials for supplemental therapy of glioblastoma…”
Get full text
Journal Article -
11
Increase of TREM2 during Aging of an Alzheimer's Disease Mouse Model Is Paralleled by Microglial Activation and Amyloidosis
Published in Frontiers in aging neuroscience (31-01-2017)“…Heterozygous missense mutations in the triggering receptor expressed on myeloid cells 2 (TREM2) have been reported to significantly increase the risk of…”
Get full text
Journal Article -
12
Impact of partial volume effect correction on cerebral β-amyloid imaging in APP-Swe mice using [18F]-florbetaben PET
Published in NeuroImage (Orlando, Fla.) (01-01-2014)“…We previously investigated the progression of β-amyloid deposition in brain of mice over-expressing amyloid-precursor protein (APP-Swe), a model of Alzheimer's…”
Get full text
Journal Article -
13
Small-Animal PET Imaging of Tau Pathology with ^sup 18^F-THK5117 in 2 Transgenic Mouse Models
Published in The Journal of nuclear medicine (1978) (01-05-2016)“…Abnormal accumulation of tau aggregates in the brain is one of the hallmarks of Alzheimer disease neuropathology. We visualized tau deposition in vivo with the…”
Get full text
Journal Article -
14
Small-Animal PET Imaging of Tau Pathology with super( 18)F-THK5117 in 2 Transgenic Mouse Models
Published in The Journal of nuclear medicine (1978) (01-05-2016)“…Abnormal accumulation of tau aggregates in the brain is one of the hallmarks of Alzheimer disease neuropathology. We visualized tau deposition in vivo with the…”
Get full text
Journal Article -
15
Small-Animal PET Imaging of Tau Pathology with 18 F-THK5117 in 2 Transgenic Mouse Models
Published in Journal of Nuclear Medicine (01-05-2016)Get full text
Journal Article -
16
Correlation of perfusion MRI and .sup.18F-FDG PET imaging biomarkers for monitoring regorafenib therapy in experimental colon carcinomas with immunohistochemical validation
Published in PloS one (10-02-2015)“…Objectives To investigate a multimodal, multiparametric perfusion MRI / .sup.18 F-fluoro-deoxyglucose-(.sup.18 F-FDG)-PET imaging protocol for monitoring…”
Get full text
Journal Article -
17
Monitoring of Tumor Growth with [(18)F]-FET PET in a Mouse Model of Glioblastoma: SUV Measurements and Volumetric Approaches
Published in Frontiers in neuroscience (14-06-2016)“…Noninvasive tumor growth monitoring is of particular interest for the evaluation of experimental glioma therapies. This study investigates the potential of…”
Get full text
Journal Article -
18
In Vivo Mesenchymal Stem Cell Tracking with PET Using the Dopamine Type 2 Receptor and 18 F-Fallypride
Published in Journal of Nuclear Medicine (01-08-2014)Get full text
Journal Article -
19
In Vivo Mesenchymal Stem Cell Tracking with PET Using the Dopamine Type 2 Receptor and sigma up 18 Theta -Fallypride
Published in The Journal of nuclear medicine (1978) (01-08-2014)“…Human mesenchymal stem cells (hMSCs) represent a promising treatment approach for tissue repair and regeneration. However, little is known about the underlying…”
Get full text
Journal Article -
20
In Vivo Mesenchymal Stem Cell Tracking with PET Using the Dopamine Type 2 Receptor and ^sup 18^F-Fallypride
Published in The Journal of nuclear medicine (1978) (01-08-2014)“…Human mesenchymal stem cells (hMSCs) represent a promising treatment approach for tissue repair and regeneration. However, little is known about the underlying…”
Get full text
Journal Article